Healthcare provider profile · identity verified

Pedro A Ballester, MD

Family Practice · WARREN, OH · NPI 1659358588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	370	96
Hydrochlorothiazide	Hydrochlorothiazide	256	71
Levothyroxine Sodium	Levothyroxine Sodium	248	63
Atorvastatin Calcium	Atorvastatin Calcium	241	73
Losartan Potassium	Losartan Potassium	237	68
Potassium Chloride	Potassium Chloride	228	70
Lisinopril	Lisinopril	210	57
Simvastatin	Simvastatin	189	50
Furosemide	Furosemide	186	55
Metoprolol Succinate	Metoprolol Succinate	186	54
Omeprazole	Omeprazole	182	50
Pantoprazole Sodium	Pantoprazole Sodium	180	59
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	160	17
Gabapentin	Gabapentin	152	36
Clopidogrel	Clopidogrel Bisulfate	150	40
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	141	11
Metoprolol Tartrate	Metoprolol Tartrate	137	38
Meloxicam	Meloxicam	130	46
Albuterol Sulfate Hfa	Albuterol Sulfate	128	34
Metformin Hcl Er	Metformin Hcl	124	37
Clonidine Hcl	Clonidine Hcl	122	36
Lorazepam	Lorazepam	121	16
Duloxetine Hcl	Duloxetine Hcl	116	28
Tramadol Hcl	Tramadol Hcl	114	19
Rosuvastatin Calcium	Rosuvastatin Calcium	107	33
Zolpidem Tartrate	Zolpidem Tartrate	107	27
Alendronate Sodium	Alendronate Sodium	106	27
Eliquis	Apixaban	100	19
Pravastatin Sodium	Pravastatin Sodium	90	24
Donepezil Hcl	Donepezil Hcl	87	26
Sertraline Hcl	Sertraline Hcl	87	27
Tamsulosin Hcl	Tamsulosin Hcl	86	27
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	83	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	21
Metformin Hcl	Metformin Hcl	79	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	22
Oxycodone Hcl	Oxycodone Hcl	67	suppressed
Clonazepam	Clonazepam	66	12
Oxybutynin Chloride Er	Oxybutynin Chloride	65	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	14
Montelukast Sodium	Montelukast Sodium	61	20
Famotidine	Famotidine	60	20
Allopurinol	Allopurinol	59	20
Azithromycin	Azithromycin	57	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	16
Liothyronine Sodium	Liothyronine Sodium	55	16
Alprazolam	Alprazolam	54	16
Glipizide Er	Glipizide	54	14
Primidone	Primidone	54	15
Amoxicillin	Amoxicillin	51	42
Ibuprofen	Ibuprofen	51	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	50	suppressed
Naproxen	Naproxen	48	19
Fluticasone Propionate	Fluticasone Propionate	46	22
Hydralazine Hcl	Hydralazine Hcl	46	14
Trazodone Hcl	Trazodone Hcl	46	14
Methylprednisolone	Methylprednisolone	45	29
Prednisone	Prednisone	44	12
Carvedilol	Carvedilol	42	13
Levetiracetam	Levetiracetam	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	31
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Fenofibrate	Fenofibrate	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Atenolol	Atenolol	35	11
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	11
Glimepiride	Glimepiride	33	11
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	11
Diazepam	Diazepam	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	15
Finasteride	Finasteride	30	11
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Meclizine Hcl	Meclizine Hcl	28	16
Warfarin Sodium	Warfarin Sodium	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	12
Mounjaro	Tirzepatide	27	suppressed
Terbinafine Hcl	Terbinafine Hcl	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Celecoxib	Celecoxib	24	11
Nifedipine Er	Nifedipine	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Minoxidil	Minoxidil	23	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Ozempic	Semaglutide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Colchicine	Colchicine	21	suppressed
Prazosin Hcl	Prazosin Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lactulose	Lactulose	16	suppressed
Ibu	Ibuprofen	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Potassium Citrate Er	Potassium Citrate	15	suppressed
Cephalexin	Cephalexin	14	12
Enalapril Maleate	Enalapril Maleate	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Torsemide	Torsemide	14	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error